Volume: 2 Issue: 2
Year: 2025, Page: 60-63, Doi: https://doi.org/10.71325/ajjms.v2i2.25.33
Received: June 23, 2025 Accepted: July 3, 2025 Published: July 16, 2025
Process validation plays a critical role in ensuring the quality, safety, and consistency of multivitamin tablet formulations across both pharmaceutical and nutraceutical sectors. Despite serving similar end-user needs, these two categories are governed by distinct regulatory frameworks, resulting in divergent validation requirements. This review presents a comparative evaluation of process validation approaches applicable to multivitamin tablets classified as either drugs or nutraceuticals. Key focus areas include differences in regulatory expectations, validation lifecycle stages, identification and control of critical process parameters (CPPs), documentation practices, and the application of quality risk management tools. The review also highlights emerging trends such as digitalization, real-time monitoring, and the adoption of Quality by Design (QbD) principles, particularly in high-risk nutraceuticals. By analyzing these aspects side by side, the article aims to assist quality assurance professionals, regulatory experts, and manufacturers in aligning validation strategies for improved compliance, product uniformity, and consumer safety. The insights provided may also support regulatory harmonization and the development of integrated quality systems across both product categories.
Keywords: Process Validation, Multivitamin Tablets, Nutraceuticals, Pharmaceuticals, Critical Process Parameters (CPPs), Quality Risk Management, GMP Compliance, Regulatory Frameworks, FSSAI, FDA, Lifecycle Approach, Quality by Design (QbD)
FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations. 2022. Available from: https://www.fssai.gov.in/upload/advisories/2022/03/6243ef28079ceDirection_Nutra_30_03_2022.pdf
US FDA. Guidance for Industry: Process Validation: General Principles and Practices. January 2011. Available from: https://www.fda.gov/media/71021/download
Codex Alimentarius. Guidelines on Nutrition Labelling and Claims. FAO/WHO. Available from: https://www.fao.org/fao-who-codexalimentarius/en/
Prabu SL, Suriyaprakash TNK, Thirumurugan R, Shanmugarathinam A. Process Validation: A Review. Pharma Times. 2014;46(4):12–15. Available from: https://www.researchgate.net/publication/290969272_Process_validation_A_review
Nash RA, Wachter AH. Pharmaceutical Process Validation (3). Marcel Dekker. 2003.
WHO Technical Report Series 986, Annex 2: Guidelines on Validation. Available from: https://www.who.int/publications/m/item/trs986-annex2
ICH Guidelines: Q8 (R2) Pharmaceutical Development, Q9 Quality Risk Management, Q10 Pharmaceutical Quality System. International Council for Harmonisation. Available from: https://www.ich.org/page/quality-guidelines
ISO 22000:2018 – Food safety management systems – Requirements for any organization in the food chain. International Organization for Standardization. Available from: https://www.iso.org/standard/65464.html
FSSC 22000 v6.0 Scheme Requirements. Foundation FSSC. 2024. Available from: https://www.fssc.com/scheme/fssc-22000-version-6/
Sharma T, Solanki NS, Mahatma OP. Process Validation: An Essential in the Pharmaceutical Industry. Int J Pharm Res Dev. 2011;3(10):133–142.
© 2025 Published by Laxmi Memorial Education Trust. This is an open-access article under CC BY 4.0 license. (https://creativecommons.org/licenses/by/4.0/)
S Vijay, Manjula Shantaram. A Comparative Evaluation of Process Validation Requirements for Multivitamin
Tablet Formulations in Nutraceutical and Drug Categories. AJ J Med Sci 2025;2(2):60–63